ALZA clinical trials
Acquired by Johnson & Johnson, Jun 22, 2001 · source ↗
The registry lists 1 studies whose lead sponsor is ALZA. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Dec 4, 2013.
Before and after it joined Johnson & Johnson
- First submitted before ALZA became part of Johnson & Johnson
- 1
- First submitted after ALZA became part of Johnson & Johnson
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- ALZA1 study
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Johnson & Johnson studies →
- Combination Chemotherapy in Treating Patients With Myelodysplastic SyndromeStatus unknownNCT00003827Phase 2
Sponsor listed in the registry: ALZA · First submitted before ALZA became part of Johnson & Johnson